Trials / Completed
CompletedNCT03791944
3DV+TPS Applied to Radiotherapy for Nasopharyngeal Carcinoma
3DV+TPS Applied to Radiotherapy for Nasopharyngeal Carcinoma - a Randomized, Single-blind, Multi-center Clinical Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Xinqiao Hospital of Chongqing · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Verify that 3DV+TPS is non-inferior compared to existing imported TPS and superior to existing domestic TPS.
Detailed description
The main purpose of the study was to verify that 3DV+TPS is non-inferior compared to existing imported TPS and superior to existing domestic TPS. A total of 100 patients were enrolled. The primary endpoint of the study was the objective response rate (ORR), and the secondary endpoint was the local control rate and the incidence of treatment-related side effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | 3DV+TPS/VARIAN | Use imported 3DV+TPS to map targets and develop treatment plans |
| DEVICE | TPS / VARIAN | Use imported TPS to map targets and develop treatment plans |
| DEVICE | 3DV + TPS / Domestic Accelerator | Use domestic 3DV+TPS to delineate target areas and develop treatment plans |
| DEVICE | TPS / Domestic Accelerator | Use domestic TPS to map targets and develop treatment plans |
Timeline
- Start date
- 2018-12-01
- Primary completion
- 2019-01-31
- Completion
- 2019-05-31
- First posted
- 2019-01-03
- Last updated
- 2024-02-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03791944. Inclusion in this directory is not an endorsement.